University of North Carolina at Chapel Hill
Dr. Fried has been involved with clinical and laboratory studies of hepatitis C since 1990 when he served for three years as a medical staff fellow in the Liver Diseases Section of the National Institutes of Health. Dr Fried has been the principal investigator on numerous Phase I, II and III clinical trials of various antiviral agents for chronic hepatitis B and hepatitis C. Since his appointment to UNC in 1998, Dr. Fried continues his commitment to the development of new and more effective treatments for these and other chronic liver diseases. Dr. Fried and his team perform clinical studies on new treatments for viral hepatitis. His work has helped to define the latest standards of care for patients with chronic hepatitis C and hepatitis B. Dr. Fried is also studying patients with chronic hepatitis C in order to investigate the effects of alcohol consumption on disease progression. His studies provide new hope in the treatment of alcohol-related diseases.